Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Evome Medical Technologies Inc V.EVMT

Alternate Symbol(s):  LNDZF

Evome Medical Technologies Inc. is an international medical device company, which is focused on human performance and rehabilitative solutions. The Company’s products include Biodex Rehab product, Damar Plastics product, Mio-Guard product, Simbex services, and SDP product. Its Biodex Rehab products include Isokinetic Systems, Gait Trainer, Body-Weight Supported Training, Cycles and Ergometers, and Squat-Assist Trainer. Its Mio-Guard products include bags, cases and kits, braces, and supports, diagnostics and instruments, furniture, and equipment, padding and splinting, personal protection, sanitizers and disinfectants, and tapes and wraps. Its applications include fall risk screening and conditioning, patient-driven payment model (PDPM), wellness, sports medicine solutions, neurological involvement, safe patient handling and mobility, and senior living and rehabilitation. It offers concussion, fall screening and balance assessment and training programs.


TSXV:EVMT - Post by User

Comment by kynarron Dec 05, 2016 5:49pm
117 Views
Post# 25557219

RE:RE:Analysis: TerraNova's Accusations re. LND/PHM/CXV Directors

RE:RE:Analysis: TerraNova's Accusations re. LND/PHM/CXV DirectorsI'll add some food for thought.

This is the company we all invested into as of Sept 29 2015:

“We are delighted at how well Inspira has grown over the last twelve months,” said David Costine, Chief Executive Officer of Inspira. “We’ve been experiencing good cash flow along with an expanding loan book and we look forward to releasing our quarterly financials due at the end of October,” continued Mr. Costine. “September was a strong month and we booked a record number of loan term sheets. At the current pace, we hope to achieve our goal of a $500 million loan book sooner than expected, without any need of additional equity capital.”

This is the company we're now invested into as of today, based on the lastest presentation they seem to have been rushed into making:

For a typical $10,000,000 revenue client: • Inspira projects it will have revenues of between $700,000 and $500,000 per year
Growth Potential 50 out of 14,000 potential clients

-

Let me make it clear in care you don't see the numbers. Over a year later, they've completely switched around the model this company bases its profits on, yet they still expect the exact same magical 500 million book number we were promised initially, this time in terms of total revenue for all 50 potential clients. The difference today is how many shares are out, how erroded the value of each of our individual shares now is, and how much the mgmt is paying THEMSELVES back in dividends, effectively killing our book value and cash flow.

But I guess this is all TerraNova's doing!
Bullboard Posts